Top of this page
Skip navigation, go straight to the content

ucb-usa.com Newsroom UCB U.S. News

Categories

  • UCB researcher, Henrik Klitgaard, Featured in PhRMA’s GOBOLDLY Campaign

    Posted by Allyson Funk, Head of U.S. Communications and Public Relations
    Dr._Henrik_Klitgaard_GoBoldly_1280x960
    Throughout November, Epilepsy Awareness Month, we’re shining a spotlight on epilepsy, a severe neurological disease that 1 in 26 people will develop in their lifetime.

    Read more

  • Disease Spotlight: Epilepsy

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    1_in_26_Epilepsy_Awareness_Month_1280x960
    This November, Epilepsy Awareness Month, we’re shining a spotlight on epilepsy – a patient community that’s near to our hearts and a research area we have been committed to for many years. Each day, we commit to helping people living with epilepsy like LaKeisha, patient advocate and life coach, achieve their dreams.

    Read more

  • UCB PharmD Fellowship Program Accepting Applications

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    GRA_Fellowship_1280x960



    Fellowship Preceptors (L to R): Oana Pop, Iram Hasan, Alexis Harper, Wanja Muthoga, Kate Kocik, Jennifer King, and Tanyja Porcha

    UCB is now accepting applications for our 2019-2021 Global Regulatory Affairs PharmD Fellowship Program through December 1, 2018.

    Read more

  • A Different Perspective on Clinical Studies

    Posted by Mitch Herndon, Patient Engagement Lead, Global Clinical Sciences & Operations
    Mitch_H_1280x960
    In this excerpt, Mitch Herndon, Patient Engagement Lead for UCB’s Global Clinical Sciences & Operations, talks about the importance of incorporating the patient perspective into clinical research studies. Read the full article on LinkedIn.

    Read more

  • Breaking the Silence on Osteoporosis

    Posted by Katelyn Snider, U.S. Communications and Public AffairsVivienne_1280x960_Blog
    It is estimated that a fragility fracture occurs every 3 seconds— totaling nearly 9 million fractures annually, worldwide. Oftentimes people think fragile bones are an inevitable part of getting older. But a broken hip or bone may more commonly be the result of an underlying condition: osteoporosis. So common that by the time you finish reading the title of this post, a fragility fracture due to osteoporosis has occurred.

    Read more

  • Disease Spotlight: Rheumatoid Arthritis

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    Deonna_for_blog_1280x960
    As part of World Arthritis Day, we’re shining a spotlight on rheumatoid arthritis (RA). Learn more about RA, which is just one of the many different types of arthritis that affect the people we’re honoring today.

    Read more

  • The Pros and Cons of a Clinical Research Study

    Posted by Katelyn Snider, U.S. Communications and Public AffairsUCB_Animation_Body_v2.gif
    Today, we’re taking a deeper dive into some of the benefits and potential disadvantages of participating in a clinical research study. These points should be used in conjunction with advice from a healthcare professional when considering if participation in a clinical research study is right for you.

    Read more

  • Supporting the Next Generation of Scientists

    Posted by Becky Malone, Engagement and Communications SpecialistAEN_photo_1280x960
    Today, our Research Triangle Park office in Raleigh, North Carolina hosted its fifth annual Academic Engagement Night.

    Read more

  • 4 Phases of Clinical Research Studies

    Posted by Katelyn Snider, U.S. Communications and Public AffairsUCB_ClinicalResearch_Static_Body
    In case you missed it, last week we covered the basics of clinical research but there is a lot more to how a drug eventually makes it to patients. In fact, only 12 percent of medicines that enter clinical research will ever make it to patients.1

    Read more

  • Clinical Research 101

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    UCB_TickingNumbers_Resize_Body.gif
    Whether it is discovering a therapy that could work for an individual patient faster or finding new ways to treat the root cause of a disease, at UCB, we are committed to continuing to unlock the science to improve the lives of patients.

    Read more